September 30, 2013

The Food and Drug Administration has approved a new usage for a drug made by UCB, the drug maker said Monday.

September 30, 2013

The Healthcare Distribution Management Association on Saturday added its voice supporting national pharmaceutical traceability legislation (Drug Quality and Security Act/H.R. 3204).

September 27, 2013

FlavoRx will start recognizing independent pharmacies that have implemented its program next month, the company said Friday.

September 24, 2013

Belgian drug maker Ablynx is licensing an experimental treatment for rheumatoid arthritis and lupus to U.S. drug maker AbbVie in a deal worth up to $840 million.

September 24, 2013

The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

September 24, 2013

The global market for Type 2 diabetes will nearly double over the next six years, according to a new report.

September 20, 2013

Perrigo Co. has hired a former Food and Drug Administration official for its regulatory department, the drug maker said.

September 19, 2013

Sanofi's vaccines division is targeting people who have not received vaccinations against flu this season in an effort to encourage them to do so.

September 19, 2013

The healthcare industry has been laser-focused on prevention since it became obvious that stemming the tide of disease in our country required an upstream solution. From tackling prediabetes in adults to preventing childhood disease with infant immunizations, health professionals are onboard — with most finding a way to incorporate disease prevention into everyday practice.

September 18, 2013

The Healthcare Distribution Management Association on Wednesday recognized three members of Congress — Sen. Michael Bennet, D-Colo.; Rep. Bob Latta, R-Ohio; and Rep. Jim Matheson, D-Utah — with the association’s Rx Safety and Healthcare Leadership Award.

September 17, 2013

Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.

September 17, 2013

Stiefel has launched a new drug for treating acne, the company said on Tuesday.

September 17, 2013

The participation of reality TV star Jack Osbourne in "Dancing with the Stars" has garnered recognition and a donation from a drug maker.

September 17, 2013

The Food and Drug Administration has approved a new formulation of a cancer drug made by Teva Pharmaceutical Industries, Teva said Tuesday.

September 16, 2013

A drug for treating opioid dependence has been launched, the manufacturer said Monday.

September 13, 2013

Cubist has completed its purchase of Trius Therapeutics, Cubist said.

September 13, 2013

Companies that make long-acting opioid painkillers will be required to conduct studies to assess their safety, while use of the drugs will be restricted, under new requirements from the Food and Drug Administration.

September 12, 2013

Dow Jones has named Abbott an industry group leader in its 2013 Dow Jones Sustainability Index, Abbott said Thursday.

September 12, 2013

Drug maker Eisai has launched a new support and savings program for patients using a weight-loss drug that it makes.

September 12, 2013

While pertussis is often considered a childhood disease, a new study from GlaxoSmithKline indicates it's a lot more common among older adults than commonly reported.

September 11, 2013

A vaccine to slow the progression of HIV and a monoclonal antibody that protects against influenza are among the nearly 300 vaccines under development by drug makers in the United States, according to a new report by a drug industry trade group.

September 11, 2013

According to Kantar Media's 2013 pharmacy study released last month, pharmacists are making more OTC product recommendations than prescription product recommendations per day.

September 10, 2013

Shareholders of Actavis and Warner Chilcott have approved the merger of the two drug makers, the companies said Tuesday.

September 10, 2013

The country's embryonic biosimilars industry scored a victory last month as the organization that runs the pension fund for California state employees announced its opposition to a state Senate bill provision that would impose special requirements on pharmacists who dispense follow-on biologics.